154 related articles for article (PubMed ID: 29463381)
1. Photocarcinogenic Risk Associated With Narrowband UV-B Phototherapy: An Epidemiologic Study in a Tertiary Care Hospital.
Ortiz-Salvador JM; Ferrer DS; Saneleuterio-Temporal M; Victoria Martínez AM; Ferriols AP; Vilata Corell JJ; Alegre de Miquel V
Actas Dermosifiliogr (Engl Ed); 2018 May; 109(4):340-345. PubMed ID: 29463381
[TBL] [Abstract][Full Text] [Related]
2. The challenge of follow-up in narrowband ultraviolet B phototherapy.
Diffey BL; Farr PM
Br J Dermatol; 2007 Aug; 157(2):344-9. PubMed ID: 17553037
[TBL] [Abstract][Full Text] [Related]
3. Melanoma and non-melanoma skin cancer in psoriatic patients treated with high-dose phototherapy.
Maiorino A; De Simone C; Perino F; Caldarola G; Peris K
J Dermatolog Treat; 2016 Oct; 27(5):443-7. PubMed ID: 26822468
[TBL] [Abstract][Full Text] [Related]
4. No evidence for increased skin cancer risk in Koreans with skin phototypes III-V treated with narrowband UVB phototherapy.
Jo SJ; Kwon HH; Choi MR; Youn JI
Acta Derm Venereol; 2011 Jan; 91(1):40-3. PubMed ID: 21031281
[TBL] [Abstract][Full Text] [Related]
5. Incidence and profile of skin cancers in patients following ultraviolet phototherapy without psoralens: A retrospective cohort study.
Wang E; Ahad T; Liu YA; Lee TK; Lui H; Crawford RI; Kalia S
J Am Acad Dermatol; 2024 Apr; 90(4):759-766. PubMed ID: 38070541
[TBL] [Abstract][Full Text] [Related]
6. Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy.
Hearn RM; Kerr AC; Rahim KF; Ferguson J; Dawe RS
Br J Dermatol; 2008 Sep; 159(4):931-5. PubMed ID: 18834483
[TBL] [Abstract][Full Text] [Related]
7. Evaluation for Skin Cancer and Precancer in Patients With Vitiligo Treated With Long-term Narrowband UV-B Phototherapy.
Bae JM; Ju HJ; Lee RW; Oh SH; Shin JH; Kang HY; Park JH; Kim HJ; Jeong KH; Lee HJ; Lee S; Kim DH; Lee DY; Kim YC; Choi GS; Kim KH; Park CJ; Choi CW;
JAMA Dermatol; 2020 May; 156(5):529-537. PubMed ID: 32159729
[TBL] [Abstract][Full Text] [Related]
8. The photocarcinogenic risk of narrowband UVB (TL-01) phototherapy: early follow-up data.
Man I; Crombie IK; Dawe RS; Ibbotson SH; Ferguson J
Br J Dermatol; 2005 Apr; 152(4):755-7. PubMed ID: 15840109
[TBL] [Abstract][Full Text] [Related]
9. Incidence of skin malignancies in patients with vitiligo or psoriasis who received narrowband ultraviolet B phototherapy (308 nm/311 nm): A retrospective review of 3730 patients.
Chia BKY; Yew YW; Zhao X; Chong WS; Thng TGS
Photodermatol Photoimmunol Photomed; 2023 Jul; 39(4):343-350. PubMed ID: 36345565
[TBL] [Abstract][Full Text] [Related]
10. Incidence of non-melanoma skin cancer in patients treated with psoralen and ultraviolet A therapy.
Ortiz Salvador JM; Pérez-Ferriols A; Alegre de Miquel V; Saneleuterio Temporal M; Vilata Corell JJ
Med Clin (Barc); 2019 Jun; 152(12):488-492. PubMed ID: 30503067
[TBL] [Abstract][Full Text] [Related]
11. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.
Archier E; Devaux S; Castela E; Gallini A; Aubin F; Le Maître M; Aractingi S; Bachelez H; Cribier B; Joly P; Jullien D; Misery L; Paul C; Ortonne JP; Richard MA
J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():22-31. PubMed ID: 22512677
[TBL] [Abstract][Full Text] [Related]
12. Is it Useful to Calculate Minimal Erythema Dose Before Narrowband UV-B Phototherapy?
Rodríguez-Granados MT; Estany-Gestal A; Pousa-Martínez M; Labandeira J; Gato Otero R; Fernández-Redondo V
Actas Dermosifiliogr; 2017 Nov; 108(9):852-858. PubMed ID: 28687116
[TBL] [Abstract][Full Text] [Related]
13. Photocarcinogenic risk of narrowband ultraviolet B (TL-01) phototherapy: early follow-up data.
Black RJ; Gavin AT
Br J Dermatol; 2006 Mar; 154(3):566-7. PubMed ID: 16445801
[No Abstract] [Full Text] [Related]
14. A cross-sectional analysis of skin cancer risk in patients receiving narrow-band ultraviolet B phototherapy: an evaluation of 100 patients.
Karaosmanoglu N; Ozdemir Cetinkaya P; Kutlu O; Karaaslan E; Imren IG; Kiratli Nalbant E; Eksioglu M
Arch Dermatol Res; 2020 May; 312(4):249-253. PubMed ID: 31729594
[TBL] [Abstract][Full Text] [Related]
15. Generalized Licen Planus Treated With Narrowband UV-B Phototherapy: Results From 10 Patients and a Review of the Literature.
Fernández-Guarino M; Aboín S; Barchino L; Arsuaga C; Lázaro Ochaita P
Actas Dermosifiliogr (Engl Ed); 2019; 110(6):490-493. PubMed ID: 30987737
[TBL] [Abstract][Full Text] [Related]
16. Ultraviolet B phototherapy does not increase the risk of skin cancer among patients with atopic dermatitis: A population-based retrospective cohort study.
Ko MJ; Tsai WC; Tsai PH; Hsu LY; Chien KL; Wu HY
J Am Acad Dermatol; 2023 Sep; 89(3):496-503. PubMed ID: 37236426
[TBL] [Abstract][Full Text] [Related]
17. Risk of skin cancer in psoriasis patients receiving long-term narrowband ultraviolet phototherapy: Results from a Taiwanese population-based cohort study.
Lin TL; Wu CY; Chang YT; Juan CK; Chen CC; Yu SH; Chen YJ
Photodermatol Photoimmunol Photomed; 2019 May; 35(3):164-171. PubMed ID: 30536640
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous carcinogenic risk evaluation in 375 patients treated with narrowband-UVB phototherapy: A 15-year experience from our Institute.
Raone B; Patrizi A; Gurioli C; Gazzola A; Ravaioli GM
Photodermatol Photoimmunol Photomed; 2018 Sep; 34(5):302-306. PubMed ID: 29533483
[TBL] [Abstract][Full Text] [Related]
19. Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo: a randomized multicenter trial.
Lim HW; Grimes PE; Agbai O; Hamzavi I; Henderson M; Haddican M; Linkner RV; Lebwohl M
JAMA Dermatol; 2015 Jan; 151(1):42-50. PubMed ID: 25230094
[TBL] [Abstract][Full Text] [Related]
20. Malignancy rates in a large cohort of patients with systemically treated psoriasis in a managed care population.
Asgari MM; Ray GT; Geier JL; Quesenberry CP
J Am Acad Dermatol; 2017 Apr; 76(4):632-638. PubMed ID: 28162854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
